KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Other Non-Current Assets (2016 - 2026)

Medtronic's Other Non-Current Assets history spans 12 years, with the latest figure at $4.0 billion for Q1 2026.

  • For Q1 2026, Other Non-Current Assets fell 4.92% year-over-year to $4.0 billion; the TTM value through Jan 2026 reached $4.0 billion, down 4.92%, while the annual FY2025 figure was $3.6 billion, 11.44% down from the prior year.
  • Other Non-Current Assets for Q1 2026 was $4.0 billion at Medtronic, up from $3.7 billion in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $4.2 billion in Q1 2025 and bottomed at $2.5 billion in Q1 2022.
  • The 5-year median for Other Non-Current Assets is $3.9 billion (2023), against an average of $3.7 billion.
  • The largest annual shift saw Other Non-Current Assets surged 31.62% in 2023 before it dropped 11.74% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $3.1 billion in 2022, then increased by 26.82% to $4.0 billion in 2023, then increased by 1.19% to $4.0 billion in 2024, then fell by 6.51% to $3.7 billion in 2025, then rose by 7.82% to $4.0 billion in 2026.
  • Per Business Quant, the three most recent readings for MDT's Other Non-Current Assets are $4.0 billion (Q1 2026), $3.7 billion (Q4 2025), and $3.6 billion (Q3 2025).